In a patient with type 2 diabetes mellitus, how should regular insulin be administered using an eight‑hour sliding‑scale regimen?

Sliding Scale Insulin Alone Should NOT Be Used in Type 2 Diabetes Patients

Regular insulin administered solely on an 8-hourly sliding scale regimen is strongly discouraged and should be replaced with a basal-bolus or basal-plus insulin regimen for hospitalized patients with type 2 diabetes. 1

Why Sliding Scale Alone Fails

The evidence against sliding scale insulin as monotherapy is compelling:

• Sliding scale insulin is associated with clinically significant hyperglycemia and has been condemned in clinical guidelines despite its continued widespread use 1
• When used alone, sliding scale regimens result in a 3-fold higher risk of hyperglycemic episodes compared to no pharmacologic treatment at all 2
• Only 6% of patients achieve good glycemic control with sliding scale insulin, with the majority (51-68%) remaining poorly controlled 3
• Sliding scale insulin is reactive rather than proactive—it treats hyperglycemia after it has already occurred rather than preventing it 1

The Superior Alternative: Basal-Bolus or Basal-Plus Regimens

Randomized trials consistently demonstrate better glycemic control with basal-bolus approaches compared to sliding scale insulin alone in type 2 diabetes patients. 1

Basal-Bolus Regimen (Preferred for Most Patients)

This approach provides comprehensive coverage and reduces complications:

• Reduces composite complications including postoperative wound infection, pneumonia, bacteremia, acute renal failure, and respiratory failure 1
• Dosing strategy: 1
  • Total daily dose: 0.3-0.5 U/kg for insulin-naive or low-dose patients
  • Split 50/50: half as basal insulin (once or twice daily), half as rapid-acting insulin (divided before three meals)
  • Add correctional insulin doses as needed
• Lower doses (closer to 0.3 U/kg) for high-risk patients: age >65 years, renal failure, poor oral intake 1
• Reduce by 20% if patient was on ≥0.6 U/kg/day at home to prevent hypoglycemia 1

Basal-Plus Regimen (For Selected Patients)

This approach is preferred for patients with mild hyperglycemia (<200 mg/dL), decreased oral intake, or those undergoing surgery: 1

• Single dose of basal insulin: 0.1-0.25 U/kg per day 1
• Correctional insulin before meals or every 6 hours if NPO 1
• Lower hypoglycemia risk compared to full basal-bolus regimen 1

The Hypoglycemia Trade-Off

While basal-bolus regimens are more effective, they carry increased hypoglycemia risk:

• Basal-bolus insulin increases hypoglycemia risk 4-6 times compared to sliding scale alone (RR 5.75 for glucose ≤70 mg/dL; RR 4.21 for glucose ≤60 mg/dL) 1
• Incidence of mild hypoglycemia with basal-bolus: 12-30% in controlled settings 1
• However, this increased hypoglycemia risk is acceptable given the substantial improvement in glycemic control and reduction in complications 1

When Sliding Scale Alone May Be Acceptable

The only appropriate use of sliding scale insulin as monotherapy is extremely limited:

• Patients without diabetes who have mild stress hyperglycemia 1
• Patients with good metabolic control on oral agents at home who cannot maintain glucose <180 mg/dL—though basal insulin may still be required 1

Critical Pitfall to Avoid

Never use sliding scale insulin alone in type 1 diabetes patients—they must continue basal insulin even if NPO to prevent diabetic ketoacidosis 1

Implementation for Regular Insulin Every 8 Hours

If you must use regular insulin on an 8-hour schedule (though rapid-acting analogs are preferred):

• Regular insulin can be given every 6 hours as correctional insulin when patients are NPO or receiving continuous enteral nutrition 1
• For enteral nutrition: Calculate 1 unit per 10-15 g carbohydrate in the formula, with NPH insulin every 8-12 hours or regular insulin every 6 hours as reasonable options 1
• Always add basal insulin coverage—do not rely on correctional doses alone 1